Boulder-based private equity firm NewVale Capital LLC recently closed its oversubscribed inaugural fund with $167 million to deploy in support of companies that provide infrastructure to the biotechnology industry. Read this story
Boulder-based private equity firm NewVale Capital LLC recently closed its oversubscribed inaugural fund with $167 million to deploy in support of companies that provide infrastructure to the biotechnology industry. Read this story
More from www.dailycamera.com | bizwest business byarsm colorado create topic dc: main Business BizWest